CLU and Insulin resistance: Although these results suggest several mechanisms by which clusterin could link insulin resistance, metabolic disease, and CVD (Figure 1), further investigation is needed to fully elucidate the cardiometabolic role of AT clusterin, and specifically clusterin derived from the adipocyte.